Lotte Shopping Co will sell 121 brick-and-mortar stores within this year amid the new coronavirus impact on the retail industry.
South Korea's biggest department store chain has initially been planning to sell 200 of them over the next three to five years but decided to hasten the process of selling less-profitable assets to improve its financial health.
The company will also focus on strengthening its e-commerce business.
On May 14, Lotte Shopping said it would shut down five department stores, 16 discount stores, 25 LOHBs outlets, and 75 supermarkets by December.
The company pointed out that while there will be no forced layoffs during the sale of the assets, some job cuts are unavoidable at the stores that would be sold.
From posting a net profit of 109.17 billion in the first quarter of last year, Lotte Shopping suffered a net loss of 43.33 billion from January to March.


Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



